AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
METOCLOPRAMIDE HYDROCHLORIDE in Zimbabwe
6 products registered with MCAZ — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| METOCLOPRAMIDE HYDROCHLORIDE TABLET; ORAL | 2023/16.2/6492 | VARICHEM PHARMACEUTICALS (PVT) LTD | active | 26 Oct 2028 |
| EMITON LIQUID | 2023/16.2/6491 | VARICHEM PHARMACEUTICALS (PVT) LTD | active | 26 Oct 2028 |
| PERILIN SOLUTION; INJECTION | 2023/16.2/6445 | LINCOLN PHARMACEUTICALS LIMITED | active | 20 Jul 2028 |
| PHARMA-Q METOCLOPRAMIDE INJECTABLE; INJECTION | 2014/16.2/4880 | PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS | active | 31 Dec 2027 |
| METOCLOPRAMIDE TABLET; ORAL | 90/16.2/2405 | WALLACE LABORATORIES PVT LTD | active | 31 Dec 2027 |
| PERILIN SOLUTION SOLUTION | 2025/16.2/6803 | LINCOLN PHARMACEUTICALS LIMITED | active | 31 Dec 2027 |
METOCLOPRAMIDE HYDROCHLORIDE — MCAZ Registration Details
MCAZ (Zimbabwe) has 6 registered products containing METOCLOPRAMIDE HYDROCHLORIDE, of which 6 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track METOCLOPRAMIDE HYDROCHLORIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.